tiprankstipranks
Trending News
More News >
Immucell Corp. (ICCC)
NASDAQ:ICCC
US Market

Immucell (ICCC) Income Statement

Compare
78 Followers

Immucell Income Statement

Last quarter (Q4 2025), Immucell's total revenue was $7.63M, a decrease of -1.61% from the same quarter last year. In Q4, Immucell's net income was $-2.85M. See Immucell’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 27.64M$ 26.49M$ 17.47M$ 18.57M$ 19.24M
Gross Profit
$ 11.45M$ 7.94M$ 4.40M$ 7.65M$ 8.66M
Operating Expenses
$ 9.80M$ 9.58M$ 10.14M$ 9.95M$ 8.40M
Depreciation and Amortization
$ 2.78M$ 2.69M$ 2.72M$ 2.49M$ 2.46M
EBITDA
$ 4.43M$ 1.07M$ -2.50M$ 349.99K$ 2.70M
Operating Income
$ 1.65M$ -1.64M$ -5.75M$ -2.30M$ 257.38K
Other Income/Expenses
$ -2.68M$ -506.41K$ -21.89K$ -186.81K$ -326.51K
Pretax Income
$ -1.03M$ -2.15M$ -5.77M$ -2.49M$ -69.13K
Net Income
$ -1.04M$ -2.16M$ -5.77M$ -2.49M$ -78.29K
Per Share Metrics
Basic EPS
$ -0.12$ -0.26$ -0.75$ -0.32$ -0.01
Diluted EPS
$ -0.12$ -0.26$ -0.75$ -0.32$ -0.01
Weighted Average Shares Outstanding
9.03M 8.17M 7.70M 7.75M 7.59M
Weighted Average Shares Outstanding (Diluted)
9.03M 8.17M 7.75M 7.75M 7.59M
Currency in USD

Immucell Earnings and Revenue History